Search Results - "Sawkins, Kate"

Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma by Field, Kathryn M, Simes, John, Nowak, Anna K, Cher, Lawrence, Wheeler, Helen, Hovey, Elizabeth J, Brown, Christopher S B, Barnes, Elizabeth H, Sawkins, Kate, Livingstone, Ann, Freilich, Ron, Phal, Pramit M, Fitt, Greg, Rosenthal, Mark A

“…The optimal use of bevacizumab in recurrent glioblastoma (GBM), including the choice of monotherapy or combination therapy, remains uncertain. The purpose of…”
Get full text

The placebo effect of ankle taping in ankle instability by SAWKINS, Kate, REFSHAUGE, Kathryn, KILBREATH, Sharon, RAYMOND, Jacqui

“…Recurrence of ankle sprains is common among athletes. Although ankle taping reduces the risk of injury, the mechanism underlying its effectiveness remains…”
Get full text

The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET) by Field, Kathryn M., Phal, Pramit M., Fitt, Greg, Goh, Christine, Nowak, Anna K., Rosenthal, Mark A., Simes, John, Barnes, Elizabeth H., Sawkins, Kate, Cher, Lawrence M., Hovey, Elizabeth J., Wheeler, Helen

“…BACKGROUND Bevacizumab has been associated with prolonged progression‐free survival for patients with recurrent glioblastoma; however, not all derive a…”
Get full text

Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma by Field, Kathryn M., King, Madeleine T., Simes, John, Espinoza, David, Barnes, Elizabeth H., Sawkins, Kate, Rosenthal, Mark A., Cher, Lawrence, Hovey, Elizabeth, Wheeler, Helen, Nowak, Anna K.

“…In recurrent glioblastoma, health-related quality of life (HRQL) is a crucial trial endpoint. We examined HRQL outcomes as a secondary endpoint for patients in…”
Get full text

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial by Hovey, Elizabeth J, Field, Kathryn M, Rosenthal, Mark A, Barnes, Elizabeth H, Cher, Lawrence, Nowak, Anna K, Wheeler, Helen, Sawkins, Kate, Livingstone, Ann, Phal, Pramit, Goh, Christine, Simes, John

“…Abstract Background In patients with recurrent glioblastoma, the benefit of bevacizumab beyond progression remains uncertain. We prospectively evaluated…”
Get full text

A randomized phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET) by Field, Kathryn Maree, Simes, John, Wheeler, Helen, Hovey, Elizabeth J., Nowak, Anna K., Cher, Lawrence, Brown, Chris, Livingstone, Ann, Sawkins, Kate, Rosenthal, Mark

“…Abstract only 2017 Background: The optimal use of bevacizumab (bev) in recurrent glioblastoma (GBM) remains uncertain including the choice between monotherapy…”
Get full text

Continuing or ceasing bevacizumab at disease progression: Results from the CABARET study, a prospective randomized phase II trial in patients with recurrent glioblastoma by Hovey, Elizabeth J., Field, Kathryn Maree, Rosenthal, Mark, Nowak, Anna K., Cher, Lawrence, Wheeler, Helen, Barnes, Elizabeth, Phal, Pramit, Livingstone, Ann, Sawkins, Kate, Simes, John

“…Abstract only…”
Get full text

Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity by Agar, Meera, Koh, Eng-Siew, Gibbs, Emma, Barnes, Elizabeth H., Hovey, Elizabeth, Livingstone, Ann, Sawkins, Kate, Chye, Richard, Lovell, Melanie R., Clark, Katherine, Vardy, Janette, King, Madeleine

“…Purpose In brain tumours, brain metastases or advanced cancer; treatment with corticosteroids, side effects can add to symptoms. These are best assessed by…”
Get full text

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial by Field, Kathryn M., Fitt, Greg, Rosenthal, Mark A., Simes, John, Nowak, Anna K., Barnes, Elizabeth H., Sawkins, Kate, Goh, Christine, Moffat, Bradford A., Salinas, Simon, Cher, Lawrence, Wheeler, Helen, Hovey, Elizabeth J., Phal, Pramit M.

“…Aim Assessment of magnetic resonance imaging (MRI) in glioblastoma can be challenging. For patients with recurrent glioblastoma managed on the CABARET trial,…”
Get full text

Culturally and linguistically diverse patient participation in glioma research by Lwin, Zarnie, Broom, Alexander, Cosman, Rasha, Livingstone, Ann, Sawkins, Kate, Good, Phillip, Kirby, Emma, Koh, Eng-Siew, Hovey, Elizabeth

“…Marginal communities, such as culturally and linguistically diverse (CALD) patients, have significantly lower rates of recruitment, accrual, and retention in…”
Get full text

Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial by Kilbreath, Sharon, Refshauge, Kathryn M, Beith, Jane, Ward, Leigh, Sawkins, Kate, Paterson, Ross, Clifton-Bligh, Philip, Sambrook, Philip N, Simpson, Judy M, Nery, Liza

“…Abstract Background Aromatase inhibitors (AIs) have improved the prognosis for breast cancer survivors and are now standard of care for postmenopausal women…”
Get full text